Anas Younes, MD
Anas Younes, MD
Professor of Medicine
Chief, Lymphoma Service
Memorial Sloan Kettering Cancer Center
New York, NY

Sundar Jagannath, MD
Sundar Jagannath, MD
Director, Multiple Myeloma Program
Professor of Medicine (Hematology and Medical Oncology)
The Tisch Cancer Institute
Mount Sinai School of Medicine
The Mount Sinai Medical Center
New York, NY

Thomas Kipps, MD, PhD
Thomas Kipps, MD, PhD
Professor of Medicine
UC San Diego Moores Cancer Center
La Jolla, CA

Harry Erba, MD, PhD
Harry P. Erba, MD, PhD
Professor of Medicine
Director, UAB Hematologic Malignancy Program
University of Alabama at Birmingham
Birmingham, AL

Accredited By

Physicians’ Education Resource®, LLC


Click here for additional educational resources for this activity.

Activity Details

Credit Type: AMA PRA Category 1 Credit
Credit Amount: 1.25
Release Date: May 19, 2014
Expiration Date: May 19, 2015
Estimated Time for Completion: 1.25 hours
Fee for Activity: Free of Charge

Activity Description

Community Practice Connections: 18th Annual International Congress on Hematologic Malignancies® is a series of short video interviews with leading experts in the treatment of hematologic malignancies who address a variety of questions commonly faced by practicing community oncologists.


See content activity as it navigates the audience through commentary woven around a series of short videos.

Learning Objectives

At the conclusion of this activity, participants should be better prepared to:

  • Evaluate emerging clinical data regarding new agents and evolving strategies for the treatment of hematologic malignancies, and apply clinical trial data appropriately in order to optimize the outcome of individual patients
  • Summarize the genomic and molecular biomarkers that have been integrated into risk assessment and treatment selection paradigms for patients with hematologic malignancies
  • Compare efficacy and safety data supporting treatment options in order to optimize outcomes for individual patients
  • Describe current strategies for individualizing therapy for patients with newly diagnosed hematologic malignancies based on assessment of transplant eligibility, patient and tumor characteristics, and risk/benefit profiles of available regimens
  • Summarize optimal supportive care strategies for preventing and treating side effects related to hematologic malignancies or their treatment
  • Select eligible patients with hematologic malignancies for promising clinical trials

Target Audience

This educational activity is directed toward community-based hematologists, medical oncologists, and fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners (NPs), nurses, physician assistants (PAs), pharmacists, researchers, and other healthcare professionals interested in the treatment of hematologic malignancies may also participate.

Requirements for Successful Completion

In order to receive a CME certificate, participants must view any number of the slide modules, complete the posttest with a passing score of 70% or higher, complete the evaluation, and request credit. Participants may immediately download a CME certificate upon completion of these steps.



Conflict of Interest Policy / Disclosure Statement

The following individuals have relevant financial relationships with commercial interests to disclose:

Harry P. Erba, MD, PhD – Grant/Research Support: Celator; Millennium Pharmaceuticals; Seattle Genetics; Amgen; Consultant: Novartis; Incyte; Seattle Genetics; Amgen; Speaker’s Bureau: Incyte; Novartis

Sundar Jagannath, MD – Consultant: Celgene Corporation; Millennium Pharmaceuticals; Merck & Co, Inc.

Anas Younes, MD – Research/Grant Support: Novartis; J&J; Seattle Genetics; Merck; Genentech; Gilead; Honorarium: Novartis; Seattle Genetics; Millennium Pharmaceuticals; Celgene Corporation; Curis; sanofi-aventis; Pharmacyclics; Incyte; Infinity

The following individuals have no relevant financial relationships with commercial interests to disclose:

Thomas Kipps, MD, PhD

The Physicians’ Education Resource®, LLC, Planning Staff – Ann C. Lichti, CCMEP, Leigh Anne Bongiovanni, and Dru Dace, PhD

Accreditation Statement for Physicians

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Statement of Commercial Support

This activity is supported by educational grants from AbbVie, Genentech, Millennium: The Takeda Oncology Company, Novartis Pharmaceuticals Corporation, and Onyx Pharmaceuticals.

Designation of Credit

Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclaimer Statement

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians’ Education Resource®, LLC, or the company that provided commercial support for this CME activity.

Disclosure of Unlabeled Use

This CME activity may contain discussions about off-label/unapproved uses of drugs. For additional information about approved uses, including approved indications, contraindications, and warnings, participants are advised to consult prescribing information for all products discussed or consult the Physicians’ Desk Reference. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.

Contact Information for Questions About the Activity

Physicians’ Education Resource®, LLC
666 Plainsboro Road, Suite 356
Plainsboro, NJ 08536
Phone: (888) 949-0045

Hardware / Software Requirements

OpenCME recommends using the latest versions of these supported browsers: Google Chrome, Mozilla Firefox, Safari; Microsoft Internet Explorer versions 8, 9, or 10. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.

Download From the ITunes App Store now!

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.